These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20973853)

  • 21. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 22. QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment.
    Stimmel B
    J Addict Dis; 2011 Oct; 30(4):307-8. PubMed ID: 22026520
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of raltegravir on the pharmacokinetics of methadone.
    Anderson MS; Mabalot Luk JA; Hanley WD; Jin B; Riesenberg RA; Wenning LA; Chodakewitz JA; Wagner JA; Iwamoto M
    J Clin Pharmacol; 2010 Dec; 50(12):1461-6. PubMed ID: 20173085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Family typology and deterioration related to opioids use, in a methadone treatment patients group].
    Garrido Fernández M; Torrado Val E; Marcos Sierra JA
    Actas Esp Psiquiatr; 2010; 38(4):196-203. PubMed ID: 21104464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Substitute drug treatments with methadone].
    von Bardeleben U; Stohler R; Petitjean S; Ladewig D
    Ther Umsch; 1993 Mar; 50(3):139-47. PubMed ID: 8475468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changes in spirometric measurements during 6 months' methadone maintenance treatment in opiate dependent patients.
    Targosz D; Kolarzyk E; Pach D
    Przegl Lek; 2001; 58(4):254-7. PubMed ID: 11450347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions.
    Russolillo A; Moniruzzaman A; Somers JM
    JAMA Netw Open; 2019 Mar; 2(3):e190595. PubMed ID: 30874778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The converging epidemics of mood-altering-drug use, HIV, HCV, and partner violence: a conundrum for methadone maintenance treatment.
    Gilbert L; El-Bassel N; Rajah V; Foleno A; Fontdevila J; Frye V; Richman BL
    Mt Sinai J Med; 2000; 67(5-6):452-64. PubMed ID: 11064497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance: high rate of other substance use disorders and relationship to psychiatric comorbidity.
    Brooner RK; Bigelow GE; Regier MW
    NIDA Res Monogr; 1989; 95():442. PubMed ID: 2641022
    [No Abstract]   [Full Text] [Related]  

  • 31. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methadone maintenance treatment for youth: experiences of clients, staff, and parents.
    Guarino HM; Marsch LA; Campbell WS; Gargano SP; Haller DL; Solhkhah R
    Subst Use Misuse; 2009; 44(14):1979-89. PubMed ID: 20001689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
    Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of Methadone Maintenance Treatment in the Maldives.
    Chengappa MN; Rao R; Suresh Kumar M
    Int J Drug Policy; 2013 Mar; 24(2):164-5. PubMed ID: 22883542
    [No Abstract]   [Full Text] [Related]  

  • 35. Why do patients stay in opioid maintenance treatment?
    Gutwinski S; Bald LK; Gallinat J; Heinz A; Bermpohl F
    Subst Use Misuse; 2014 May; 49(6):694-9. PubMed ID: 24328842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone maintenance treatment. When and how to refer patients.
    DeMaria PA; Weinstein SP
    Postgrad Med; 1995 Mar; 97(3):83-6, 91-2. PubMed ID: 7877931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients].
    Ortner R; Peternell A; Kraigher D; Schindler S; Topitz A; Fischer G
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):934-8. PubMed ID: 11802509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.